Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Proteostasis Therapeutics Inc    PTI

PROTEOSTASIS THERAPEUTICS INC

(PTI)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector news

Proteostasis Therapeutics Up 25%; BlackRock Disclosed 5.9% Stake Friday

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/11/2019 | 03:07pm EDT

By Josh Beckerman

Shares of biopharmaceutical company Proteostasis Therapeutics recently traded up 25.2% to $4.02.

Late Friday, BlackRock disclosed a 5.9% stake in Proteostasis.

In December, Proteostasis announced a licensing agreement with Roche Holding Genentech unit.

Write to Josh Beckerman at josh.beckerman@wsj.com

Stocks mentioned in the article
ChangeLast1st jan.
BLACKROCK INC -0.39% 465.69 Delayed Quote.18.55%
PROTEOSTASIS THERAPEUTICS INC -4.76% 1.2 Delayed Quote.-62.96%
ROCHE HOLDING LTD. -1.09% 263.4 Delayed Quote.8.22%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on PROTEOSTASIS THERAPEUTICS
03/29PROTEOSTASIS THERAPEUTICS, INC. : Termination of a Material Definitive Agreement..
AQ
03/25PROTEOSTASIS THERAPEUTICS, INC. : Regulation FD Disclosure, Other Events, Financ..
AQ
03/25PROTEOSTASIS THERAPEUTICS : Announces Broad New Dataset from Proprietary Combina..
PR
03/08PROTEOSTASIS THERAPEUTICS : Management's Discussion and Analysis of Financial Co..
AQ
03/07PROTEOSTASIS THERAPEUTICS : Appoints David Arkowitz to Board of Directors
PR
02/27PROTEOSTASIS THERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements..
AQ
02/27PROTEOSTASIS THERAPEUTICS : Selected to Join European Consortium to Pioneer Pers..
PR
02/20PROTEOSTASIS THERAPEUTICS : to Present at the 8th Annual SVB Leerink Global Heal..
PR
02/11PROTEOSTASIS THERAPEUTICS, INC. : Change in Directors or Principal Officers (for..
AQ
02/11Proteostasis Therapeutics Up 25%; BlackRock Disclosed 5.9% Stake Friday
DJ
More news
Financials ($)
Sales 2019 1,63 M
EBIT 2019 -89,7 M
Net income 2019 -88,2 M
Debt 2019 -
Yield 2019 -
P/E ratio 2019 -
P/E ratio 2020
EV / Sales 2019 37,7x
EV / Sales 2020 15,6x
Capitalization 61,2 M
Chart PROTEOSTASIS THERAPEUTICS INC
Duration : Period :
Proteostasis Therapeutics Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PROTEOSTASIS THERAPEUTICS
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 11,6 $
Spread / Average Target 867%
EPS Revisions
Managers
NameTitle
Meenu Chhabra Karson President, Chief Executive Officer & Director
Michael James Barrett Chairman
Marija Zecevic Chief Operating Officer
Helen M. Boudreau Treasurer, Chief Financial & Accounting Officer
Po-Shun Lee Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
PROTEOSTASIS THERAPEUTICS INC-62.96%61
GILEAD SCIENCES0.64%80 255
VERTEX PHARMACEUTICALS1.48%42 991
REGENERON PHARMACEUTICALS-10.75%35 789
GENMAB5.11%10 418
SAREPTA THERAPEUTICS INC6.88%8 594